Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients: Differences in angiogenic status between adenocarcinoma histologic subtypes

Ryo Maeda, Genichiro Ishii, Masami Ito, Tomoyuki Hishida, Junji Yoshida, Mitsuyo Nishimura, Hironori Haga, Kanji Nagai, Atsushi Ochiai

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Angiogenesis plays a significant role in tumor progression. This study examined the association between the number of circulating endothelial progenitor cells (EPCs), intratumoral microvessel density (MVD) (both of which may be markers for neovascularization), and lung cancer histological types, particularly adenocarcinoma histological subtypes. Methods: A total of 83 stage I non-small cell lung cancer (NSCLC) patients underwent complete tumor resection between November 2009 and July 2010. The number of EPCs from the pulmonary artery of the resected lungs was measured by assaying CD34 +/vascular endothelial growth factor receptor 2 positive cells, and the MVD was assessed immunohistochemically in tumor specimens by staining for CD34. Results: A statistically significant correlation between the number of EPCs from pulmonary artery and intratumoral MVD was found (p < 0.001). No statistically significant differences in the number of EPCs and the MVD were observed between the adenocarcinomas and the squamous cell carcinomas. Among the adenocarcinoma histological subtypes, a higher number of EPCs and MVD were found significantly more frequently in solid adenocarcinomas than in nonsolid adenocarcinomas (p < 0.001 and p = 0.011, respectively). In addition, solid adenocarcinomas showed higher levels of vascular endothelial growth factor using quantitative real-time polymerase chain reaction in the tumor tissue samples than in the nonsolid adenocarcinomas (p = 0.005). Conclusion: The higher number of circulating EPCs and the MVD of solid adenocarcinoma may indicate the presence of differences in the tumor angiogenic status between early-stage adenocarcinoma histological subtypes. Among adenocarcinoma patients, patients with solid adenocarcinoma may be the best candidates for antiangiogenic therapies.

Original languageEnglish
Pages (from-to)503-511
Number of pages9
JournalJournal of Thoracic Oncology
Volume7
Issue number3
DOIs
Publication statusPublished - 2012 Mar
Externally publishedYes

Fingerprint

Microvessels
Non-Small Cell Lung Carcinoma
Adenocarcinoma
Cell Count
Neoplasms
Pulmonary Artery
Endothelial Progenitor Cells
Vascular Endothelial Growth Factor Receptor-2
Vascular Endothelial Growth Factor A
Real-Time Polymerase Chain Reaction
Squamous Cell Carcinoma
Lung Neoplasms
Staining and Labeling
Lung

Keywords

  • Adenocarcinoma
  • Angiogenesis
  • Circulating endothelial progenitor cell
  • Non-small cell lung cancer
  • Subtypes

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this

Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients : Differences in angiogenic status between adenocarcinoma histologic subtypes. / Maeda, Ryo; Ishii, Genichiro; Ito, Masami; Hishida, Tomoyuki; Yoshida, Junji; Nishimura, Mitsuyo; Haga, Hironori; Nagai, Kanji; Ochiai, Atsushi.

In: Journal of Thoracic Oncology, Vol. 7, No. 3, 03.2012, p. 503-511.

Research output: Contribution to journalArticle

Maeda, Ryo ; Ishii, Genichiro ; Ito, Masami ; Hishida, Tomoyuki ; Yoshida, Junji ; Nishimura, Mitsuyo ; Haga, Hironori ; Nagai, Kanji ; Ochiai, Atsushi. / Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients : Differences in angiogenic status between adenocarcinoma histologic subtypes. In: Journal of Thoracic Oncology. 2012 ; Vol. 7, No. 3. pp. 503-511.
@article{a73de4a35f314b21ab6616cdbee604d9,
title = "Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients: Differences in angiogenic status between adenocarcinoma histologic subtypes",
abstract = "Angiogenesis plays a significant role in tumor progression. This study examined the association between the number of circulating endothelial progenitor cells (EPCs), intratumoral microvessel density (MVD) (both of which may be markers for neovascularization), and lung cancer histological types, particularly adenocarcinoma histological subtypes. Methods: A total of 83 stage I non-small cell lung cancer (NSCLC) patients underwent complete tumor resection between November 2009 and July 2010. The number of EPCs from the pulmonary artery of the resected lungs was measured by assaying CD34 +/vascular endothelial growth factor receptor 2 positive cells, and the MVD was assessed immunohistochemically in tumor specimens by staining for CD34. Results: A statistically significant correlation between the number of EPCs from pulmonary artery and intratumoral MVD was found (p < 0.001). No statistically significant differences in the number of EPCs and the MVD were observed between the adenocarcinomas and the squamous cell carcinomas. Among the adenocarcinoma histological subtypes, a higher number of EPCs and MVD were found significantly more frequently in solid adenocarcinomas than in nonsolid adenocarcinomas (p < 0.001 and p = 0.011, respectively). In addition, solid adenocarcinomas showed higher levels of vascular endothelial growth factor using quantitative real-time polymerase chain reaction in the tumor tissue samples than in the nonsolid adenocarcinomas (p = 0.005). Conclusion: The higher number of circulating EPCs and the MVD of solid adenocarcinoma may indicate the presence of differences in the tumor angiogenic status between early-stage adenocarcinoma histological subtypes. Among adenocarcinoma patients, patients with solid adenocarcinoma may be the best candidates for antiangiogenic therapies.",
keywords = "Adenocarcinoma, Angiogenesis, Circulating endothelial progenitor cell, Non-small cell lung cancer, Subtypes",
author = "Ryo Maeda and Genichiro Ishii and Masami Ito and Tomoyuki Hishida and Junji Yoshida and Mitsuyo Nishimura and Hironori Haga and Kanji Nagai and Atsushi Ochiai",
year = "2012",
month = "3",
doi = "10.1097/JTO.0b013e318241780e",
language = "English",
volume = "7",
pages = "503--511",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
publisher = "International Association for the Study of Lung Cancer",
number = "3",

}

TY - JOUR

T1 - Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients

T2 - Differences in angiogenic status between adenocarcinoma histologic subtypes

AU - Maeda, Ryo

AU - Ishii, Genichiro

AU - Ito, Masami

AU - Hishida, Tomoyuki

AU - Yoshida, Junji

AU - Nishimura, Mitsuyo

AU - Haga, Hironori

AU - Nagai, Kanji

AU - Ochiai, Atsushi

PY - 2012/3

Y1 - 2012/3

N2 - Angiogenesis plays a significant role in tumor progression. This study examined the association between the number of circulating endothelial progenitor cells (EPCs), intratumoral microvessel density (MVD) (both of which may be markers for neovascularization), and lung cancer histological types, particularly adenocarcinoma histological subtypes. Methods: A total of 83 stage I non-small cell lung cancer (NSCLC) patients underwent complete tumor resection between November 2009 and July 2010. The number of EPCs from the pulmonary artery of the resected lungs was measured by assaying CD34 +/vascular endothelial growth factor receptor 2 positive cells, and the MVD was assessed immunohistochemically in tumor specimens by staining for CD34. Results: A statistically significant correlation between the number of EPCs from pulmonary artery and intratumoral MVD was found (p < 0.001). No statistically significant differences in the number of EPCs and the MVD were observed between the adenocarcinomas and the squamous cell carcinomas. Among the adenocarcinoma histological subtypes, a higher number of EPCs and MVD were found significantly more frequently in solid adenocarcinomas than in nonsolid adenocarcinomas (p < 0.001 and p = 0.011, respectively). In addition, solid adenocarcinomas showed higher levels of vascular endothelial growth factor using quantitative real-time polymerase chain reaction in the tumor tissue samples than in the nonsolid adenocarcinomas (p = 0.005). Conclusion: The higher number of circulating EPCs and the MVD of solid adenocarcinoma may indicate the presence of differences in the tumor angiogenic status between early-stage adenocarcinoma histological subtypes. Among adenocarcinoma patients, patients with solid adenocarcinoma may be the best candidates for antiangiogenic therapies.

AB - Angiogenesis plays a significant role in tumor progression. This study examined the association between the number of circulating endothelial progenitor cells (EPCs), intratumoral microvessel density (MVD) (both of which may be markers for neovascularization), and lung cancer histological types, particularly adenocarcinoma histological subtypes. Methods: A total of 83 stage I non-small cell lung cancer (NSCLC) patients underwent complete tumor resection between November 2009 and July 2010. The number of EPCs from the pulmonary artery of the resected lungs was measured by assaying CD34 +/vascular endothelial growth factor receptor 2 positive cells, and the MVD was assessed immunohistochemically in tumor specimens by staining for CD34. Results: A statistically significant correlation between the number of EPCs from pulmonary artery and intratumoral MVD was found (p < 0.001). No statistically significant differences in the number of EPCs and the MVD were observed between the adenocarcinomas and the squamous cell carcinomas. Among the adenocarcinoma histological subtypes, a higher number of EPCs and MVD were found significantly more frequently in solid adenocarcinomas than in nonsolid adenocarcinomas (p < 0.001 and p = 0.011, respectively). In addition, solid adenocarcinomas showed higher levels of vascular endothelial growth factor using quantitative real-time polymerase chain reaction in the tumor tissue samples than in the nonsolid adenocarcinomas (p = 0.005). Conclusion: The higher number of circulating EPCs and the MVD of solid adenocarcinoma may indicate the presence of differences in the tumor angiogenic status between early-stage adenocarcinoma histological subtypes. Among adenocarcinoma patients, patients with solid adenocarcinoma may be the best candidates for antiangiogenic therapies.

KW - Adenocarcinoma

KW - Angiogenesis

KW - Circulating endothelial progenitor cell

KW - Non-small cell lung cancer

KW - Subtypes

UR - http://www.scopus.com/inward/record.url?scp=84857920964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857920964&partnerID=8YFLogxK

U2 - 10.1097/JTO.0b013e318241780e

DO - 10.1097/JTO.0b013e318241780e

M3 - Article

C2 - 22198428

AN - SCOPUS:84857920964

VL - 7

SP - 503

EP - 511

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

SN - 1556-0864

IS - 3

ER -